Cationic porphyrazines with morpholinoethyl substituents – Syntheses, optical properties, and photocytotoxicities
Source abstract
Abstract
Novel cationic water-soluble magnesium(II) and zinc(II) sulfanyl porphyrazines with peripheral N-methylmorpholinoethyl iodide moieties in the form of iodide salts were synthesized and characterized with ESI MS, UV–Vis, and NMR. The subsequent logPo/w values were lower for octaiodide salts than those for their neutral precursors and, therefore the macrocycles were considered hydrophilic. After measuring the binding constants Kb, it becomes clear that the obtained cationic porphyrazines, as well as the neutral porphyrazines, were poor liposome binders. The cationic water-soluble magnesium(II) and zinc(II) sulfanyl porphyrazines revealed moderate singlet oxygen generation yields and higher susceptibility to decomposition after light exposition. In the antimicrobial studies, magnesium(II) porphyrazine with peripheral N-methylmorpholinoethyl groups presented a log reduction up to 6.5 against Gram-positive bacteria. In vitro, photocytotoxic activity assessments of magnesium(II) and zinc(II) porphyrazines with peripheral N-methylmorpholinoethyl, as well as magnesium(II) sulfanyl porphyrazine derivative in the form of iodide salt, were performed on two types of oral cancer cells – SCC-25 and CAL-27. Zinc(II) sulfanyl porphyrazine with peripheral N-methylmorpholinoethyl groups decreased the viability of the SCC-25 cell line after light irradiation with IC50 at 6.46 μM in its free form and at 3.61 μM after encapsulation in liposomal formulation. The opposite phenomenon was observed for magnesium(II) sulfanyl porphyrazine with peripheral N-methylmorpholinoethyl groups. The magnesium(II) sulfanyl porphyrazine derivative in the form of iodide salt did not demonstrate any photocytotoxicity in the studied cell lines.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Porphyrin and Phthalocyanine Chemistry · Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (83)
Show source-provided references
1. What we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles10.1007/s10928-017-9506-4 ↗
2. Comparison of antibiotic resistance and virulence in vancomycin-susceptible and vancomycin-resistant Enterococcus faecium strains10.20883/jms.288 ↗
3. Photoantimicrobials—are we afraid of the light?10.1016/S1473-3099(16)30268-7 ↗
4. Photosensitizers in clinical PDT10.1016/S1572-1000(04)00007-9 ↗
5. Oncologic photodynamic therapy photosensitizers: a clinical review10.1016/j.pdpdt.2010.02.001 ↗
6. Photodynamic therapy of cancer: an update
7. Cellular changes, molecular pathways and the immune system following photodynamic treatment10.2174/0929867321666140826120300 ↗
8. Photosensitizers mediated photodynamic inactivation against virus particles10.2174/1389557515666150415151505 ↗
9. Activatable photosensitizers for imaging and therapy10.1021/cr900236h ↗
10. Current status of liposomal porphyrinoid photosensitizers10.1016/j.drudis.2013.04.003 ↗
11. Functionality stored in the structures of cyclodextrin–porphyrinoid systems10.1016/j.ccr.2015.04.009 ↗
12. Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis10.1186/s12879-021-05763-y ↗
13. Bacterial infection among cancer patients: analysis of isolates and antibiotic sensitivity pattern10.1155/2021/8883700 ↗
14. A comparative analysis of infection in patients with malignant cancer: a clinical pharmacist consultation study10.1016/j.jiph.2019.03.021 ↗
15. Bacteria and tumours: causative agents or opportunistic inhabitants?10.1186/1750-9378-8-11 ↗
16. Bacterial and fungal microflora in surgically removed lung cancer samples10.1186/1749-8090-6-137 ↗
17. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma10.1101/gr.126516.111 ↗
18. Photodynamic therapy in dentistry10.1177/154405910708600803 ↗
19. Porphyrinoids in photodynamic diagnosis and therapy of oral diseases10.1142/S108842461850116X ↗
20. Photodynamic therapy in root canals contaminated with Enterococcus faecalis using curcumin as photosensitizer10.1007/s10103-014-1696-z ↗
21. Photodynamic killing of Enterococcus faecalis in dentinal tubules using mTHPC incorporated in liposomes and invasomes10.1007/s00784-014-1271-9 ↗
22. Enterococcus faecalis–the root canal survivor and ‘star’in post-treatment disease10.1111/j.1601-1546.2003.00040.x ↗
23. In vitro photodynamic activity of lipid vesicles with zinc phthalocyanine derivative against Enterococcus faecalis10.1016/j.jphotobiol.2018.04.025 ↗
24. Chlorins with (trifluoromethyl)phenyl substituents – synthesis, lipid formulation and photodynamic activity against bacteria10.1016/j.dyepig.2018.08.004 ↗
25. Optical properties of a series of pyrrolyl-substituted porphyrazines and their photoinactivation potential against Enterococcus faecalis after incorporation into liposomes10.1016/j.jphotochem.2018.09.015 ↗
26. Lipid vesicle-loaded meso-substituted chlorins of high in vitro antimicrobial photodynamic activity10.1039/c8pp00258d ↗
27. Photodynamic inactivation of Enterococcus faecalis by non-peripherally substituted magnesium phthalocyanines entrapped in lipid vesicles10.1016/j.jphotobiol.2018.09.003 ↗
28. Uptake pathways of anionic and cationic photosensitizers into bacteria10.1039/b809624d ↗
29. The role of environmental changes on monospecies biofilm formation on root canal wall by Enterococcus faecalis10.1097/01.don.0000164855.98346.fc ↗
30. Trends in incidence of cancers of the oral cavity and pharynx — United States 2007–201610.15585/mmwr.mm6915a1 ↗
31. Causes of oral cancer – an appraisal of controversies10.1038/sj.bdj.2009.1009 ↗
32. Oral cancer: a multicenter study
33. Reduced graphene oxide/iron(II) porphyrazine hybrids on glassy carbon electrode for amperometric detection of NADH and L-cysteine10.1016/j.jelechem.2019.113322 ↗
34. Sulfanyl porphyrazines with morpholinylethyl periphery—synthesis, electrochemistry, and photocatalytic studies after deposition on titanium(IV) oxide P25 nanoparticles10.3390/molecules26082280 ↗
35. Physicochemical properties of liposome-incorporated 2-(morpholin-4-yl)ethoxy phthalocyanines and their photodynamic activity against oral cancer cells10.1016/j.jphotochem.2017.12.005 ↗
36. Photochemical properties and photocytotoxicities against wound bacteria of sulfanyl porphyrazines with bulky peripheral substituents10.1016/j.jorganchem.2020.121669 ↗
37. Quantitative and site-directed chemical modification of hypocrellins toward direct drug delivery and effective photodynamic activity10.1021/jm2017368 ↗
38. Antimicrobial and anticancer photodynamic activity of a phthalocyanine photosensitizer with N -methyl morpholiniumethoxy substituents in non-peripheral positions10.1016/j.jinorgbio.2017.04.009 ↗
39. Liposome binding constants and singlet oxygen quantum yields of hypericin, tetrahydroxy helianthrone and their derivatives: studies in organic solutions and in liposomes10.1016/S1011-1344(00)00090-7 ↗
40. Enhanced acidity, photophysical properties and liposome binding of perfluoroalkylated phthalocyanines lacking C-H bonds10.1562/2005-11-08-RA-732 ↗
41. Functional singlet oxygen generators based on porphyrazines with peripheral 2,5-dimethylpyrrol-1-yl and dimethylamino groups10.1016/j.jphotochem.2013.06.018 ↗
42. Photochemical studies of tetra-2, 3-pyridinoporphyrazines10.1016/S1010-6030(01)00427-0 ↗
43. Novel gallium(III) phthalocyanine derivatives – synthesis, photophysics and photochemistry10.1016/j.poly.2007.01.016 ↗
44. Solvent effects on the photochemical and fluorescence properties of zinc phthalocyanine derivatives10.1016/S0022-2860(03)00155-8 ↗
45. Photodynamic inactivation of Enterococcus faecalis by conjugates of zinc(II) phthalocyanines with thymol and carvacrol loaded into lipid vesicles10.1016/j.ica.2019.02.031 ↗
46. Photooxidation of metallophthalocyanines: the effects of singlet oxygen and PcM-O 2 complex formation10.1142/S1088424605000496 ↗
47. Study on the photostability of water-soluble Zn(II) and Al(III) phthalocyanines in aqueous solution10.1142/S1088424610002835 ↗
48. A facile and regioselective synthesis of trans-heterofunctionalized porphyrazine derivatives10.1021/jo971683c ↗
49. Roncucci G. Zinc-phthalocyanines and corresponding conjugates, their preparation and use in photodynamic therapy and as diagnostic agents, vol. 5; 1999. 965,598. United States Patent, Patent Number: 5,965,598, Date of Patent: Oct. 12, 1999.
50. Synthesis of sulfanyl porphyrazines with bulky peripheral substituents – evaluation of their photochemical properties and biological activity10.1016/j.jphotochem.2020.112964 ↗
51. Tetra(3,4-pyrido)porphyrazines caught in the cationic cage: toward nanomolar active photosensitizers10.1021/acs.jmedchem.6b01140 ↗
52. Water-soluble quaternized mercaptopyridine-substituted zinc-phthalocyanines: synthesis, photophysical, photochemical and bovine serum albumin binding properties10.1016/j.dyepig.2011.02.007 ↗
53. The synthesis and investigation of binding properties of a new water soluble hexadeca zinc(II) phthalocyanine with bovine serum albumin and DNA10.1039/C5NJ00933B ↗
54. A non-aggregated zinc(II) phthalocyanine with hexadeca cations for antitumor and antibacterial photodynamic therapies10.1016/j.jphotobiol.2020.112086 ↗
55. Synthesis, characterization and staining performance of peripherally and non-peripherally substituted metallo-phthalocyanines bearing 1,3-bis-(trimethylamino)-2-propoxy groups10.1039/D0NJ01404D ↗
56. The new water soluble zinc(II) phthalocyanines substituted with morpholine groups- synthesis and optical properties10.1016/j.jphotochem.2020.112736 ↗
57. Determination of n-octanol/water partition and membrane binding of cationic porphyrins10.1016/j.ijpharm.2006.08.008 ↗
58. On the correlation between hydrophobicity, liposome binding and cellular uptake of porphyrin sensitizers10.1562/2005-09-01-RA-669 ↗
59. Spectroscopy, binding to liposomes and production of singlet oxygen by porphyrazines with modularly variable water solubility10.1111/j.1751-1097.2007.00268.x ↗
60. Photochemical studies and nanomolar photodynamic activities of phthalocyanines functionalized with 1,4,7-trioxanonyl moieties at their non-peripheral positions10.1016/j.jinorgbio.2015.11.006 ↗
61. Photochemical properties and promising activity against staphylococci of sulfanyl porphyrazines with dendrimeric moieties10.1016/j.ica.2021.120321 ↗
62. Porphyrazines with peripheral isophthaloxyalkylsulfanyl substituents and their optical properties10.1016/j.jphotochem.2015.04.003 ↗
63. Synthesis, characterization, photochemical properties and cytotoxicity of the novel porphyrazine functionalized with nitroimidazolylbutylsulfanyl groups10.1016/j.inoche.2013.01.001 ↗
64. Photophysical properties and photochemistry of a sulfanyl porphyrazine bearing isophthaloxybutyl substituents10.1016/j.dyepig.2014.10.004 ↗
65. Sulfanyl porphyrazines: molecular barrel-like self-assembly in crystals, optical properties and in vitro photodynamic activity towards cancer cells10.1016/j.dyepig.2016.09.054 ↗
66. Functional singlet oxygen generators based on phthalocyanines10.1016/j.ccr.2012.03.022 ↗
67. Oxidative photobleaching of phthalocyanines in solution10.1142/S1088424612300042 ↗
68. Sulfonated phthalocyanines: aggregation and singlet oxygen quantum yield in aqueous solutions10.1142/S1088424603000203 ↗
69. The synthesis, fluorescence behaviour and singlet oxygen studies of new water-soluble cationic gallium(III) phthalocyanines10.1016/j.inoche.2006.11.012 ↗
70. Photosensitized singlet oxygen and its applications10.1016/S0010-8545(02)00034-6 ↗
71. The peripheral and non-peripheral 2H-benzotriazole substituted phthalocyanines: synthesis, characterization, photophysical and photochemical studies of zinc derivatives10.1016/j.saa.2019.01.095 ↗
72. 2012
73. Photochemical transformations involving magnesium porphyrins and phthalocyanines
74. Synthesis, spectroscopic properties and interaction with a liposomal membrane of a novel iodinated magnesium phthalocyanine10.1016/j.jphotochem.2014.04.006 ↗
75. Aggregation control of robust water-soluble zinc(II) phthalocyanine-based photosensitizers10.1021/acs.langmuir.6b03552 ↗
76. Porphyrinoid photosensitizers mediated photodynamic inactivation against bacteria10.1016/j.ejmech.2019.04.057 ↗
77. Non-porphyrinoid photosensitizers mediated photodynamic inactivation against bacteria10.1016/j.dyepig.2018.12.014 ↗
78. Treatment of head and neck cancer with photodynamic therapy with redaporfin: a clinical case report10.1159/000493423 ↗
79. The efficacy of photodynamic therapy in the treatment of oral squamous cell carcinoma: a meta-analysis10.1177/014556131509400208 ↗
80. Anionic water-soluble sulfonated phthalocyanines: microwave-assisted synthesis, aggregation behaviours, electrochemical and in-situ spectroelectrochemical characterisation10.1080/10610278.2017.1288232 ↗
81. Synthesis of sulfanyl porphyrazines with bulky peripheral substituents – evaluation of their photochemical properties and biological activity10.1016/j.jphotochem.2020.112964 ↗
82. Immunological and toxicological considerations for the design of liposomes10.3390/nano10020190 ↗
83. Liposomal formulations of magnesium sulfanyl tribenzoporphyrazines for the photodynamic therapy of cancer10.1016/j.jinorgbio.2018.04.010 ↗